Kemerovo, Kemerovo, Russian Federation
Kemerovo, Kemerovo, Russian Federation
Russian Federation
Russian Federation
Russian Federation
UDK 61 Медицина. Охрана здоровья
The study included 72 men with a reliable diagnosis of AS, mean age – 43,2±9,1 years. X-ray examination of the axial skeleton and peripheral joints was carried out, HLA-B27 was determined. Disease activity was assessed using the index ВАSDАI, functional disorders with the help of the BASFI index. BMD was determined by two-energy x-ray absorptiometry. The control group consisted of 74 healthy men, mean age – 46,7±0,9 years. Given the chronic nature and asymptomatic course of osteoporosis, the task of doctors working with this group of patients is an active search for osteoporosis using all available diagnostic techniques for the early detection of this condition and subsequent correction of the drug treatment.
ankylosing spondylitis, osteoporosis
1. Revmatologiya. Rossiyskie klinicheskie rekomendacii / pod redakciey EL Nasonova M.: GEOTAR-Media, 2017. 456 s. [Rheumatology. Russian clinical guidelines. Nasonov EL, editors. Moscow: GEOTAR-Media Publ., 2017.456 p. (In Russ.)].
2. Godzenko AA. Vneskeletnye proyavleniya ankiloziruyuschego spondilita: klinika, techenie, prognoz: avtoref. dis. … d-ra med. nauk. Moskva, 2018. 38 s. [Godzenko AA. Non-skeletal manifestations of ankylosing spondylitis: clinic, course, prognosis. Dr. med. sci. abstracts diss. Moscow, 2018. 38 p. (In Russ.)].
3. Myasoutova LI, Lapshina SA, Salihov IG. Izmenenie mineral'noy plotnosti kostnoy tkani u bol'nyh ankiloziruyuschim spondiloartritom. Osteoporoz i osteopatii. 2011;(3):14-18 [Myasoutova LI, Lapshina SA, Salikhov IG. The change in mineral bone density in patients with ankylosing spondylitis. Osteoporosis and osteopathy. 2011; (3):14-18 (In Russ.)].
4. Gubar' EE, Erdes ShF. Osteoporoz u bol'nyh ankiloziruyuschim spondilitom. Nauchno-prakticheskaya revmatologiya. 2013;51(5):53-62 [Gubar EE, Erdes SF. Osteoporosis in patients with ankylosing spondylitis. Rheumatology sciense-practice. 2013;51(5):53-62 (In Russ.)].
5. Lange U, Kluge A, Strunk J et al. Ankylosing spondylitis and bone mineral density - what is the ideal tool for measurement? Rheumatol. Int. 2005;26(2):115-120.
6. Kaya A, Ozgocmen S, Kamanli A. et al. Bone loss in ankylosing spondylitis: does syndesmophyte formation have an influence on bone density changes? Med. Princ. Pract.2009;18(6):470-476.
7. Benevolenskaya LI, Lesnyak OM. Osteoporoz. Diagnostika, profilaktika i lechenie. Klinicheskie rekomendacii. M.: GEOTAR-Media, 2011.14s. [Benevalenskaya LI, Lesnyak OM. Osteoporosis. Diagnosis, prevention and treatment. Clinical guidelines. Moskow: GEOTAR-Media, 2011. 14p. (In Russ.)].
8. Kim HR, Kim HY, Lee SH. Elevated serum levels of soluble receptor activator of nuclear factors-kB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis. J. Rheumatology. 2006;45(10):1197-1200.
9. Altindag O, Erel O, Soran N et al. Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis. Rheumatol Int. 2008;28:317-321.
10. Ghozlani I, Ghazi M, Nouijai A, Mounach A, Rezqi A, Achemlal L, et al. Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone. 2009;44(5):772-776. doi:https://doi.org/10.1016/j.bone.2008.12.028.
11. Mermerci BB. Comparison of the Bath Ankylosing Spondylitis Radiology Index and the modified Stoke Ankylosing Spondylitis Spine Score in Turkish patients with ankylosing spondylitis. Clinical Rheumatology. 2009; 29(1):65-70.
12. Ramirez J, Nieto-González JC, Curbelo Rodríguez R, Castañeda S, Carmona L. Prevalence and risk factors for osteoporosis and fractures in axial spondyloarthritis: A systematic review and meta-analysis. Semin Arthritis Rheum. 2018; 48 (1): 44-52. doi:https://doi.org/10.1016/j.semarthrit.2017.12.001.
13. Borcan M, Matei D, Popescu R. Management of osteoporosis in ankylosing spondylitis. Osteoporosis Int. 2011;22(1):309-310.
14. Baskan BV, Dogan YP, Sivas F. The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis. Rheumatol. Int. 2010;30(3):375-381.
15. Lange U, Boss B, Teichmann J. et al. Serum amyloid A - an indicator of inflammation in ankylosing spondylitis . Reumatol. Int. 2000;19(4):119-122.
16. Braun J, van den Berg R, Baraliakos X et al. Update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann. Rheum. Dis. 2011;70(6):896-904.
17. Toussirot E, Michel F, Wendling D. Bone density, ultrasound measurements and body composition in early ankylosing spondylitis. Rheumatology (Oxford). 2001;40(8):882-888.
18. Capaci K, Hepguler S, Argin M. et al. Bone mineral density in mild and advanced ankylosing spondylitis. Yonsei Med. J. 2003;44(3):379-384.
19. Gratacos J, Collado A, Pons F. et al. Significant loss of bone mass in patients with early, active ankylosing spondylitis : follow up study. Arthritis Rheum. 1999;42(11):2319-2324.
20. Derakhshan M, Goodson N, Packham J, et al. Hip osteoporosis and vertebral fractures are associated with younger age at diagnosis of spondyloarthritis: results from the comospa study. Annals of the Rheumatic Diseases. 2017;76:13083.
21. Zhang Min et al. The association between ankylosing spondylitis and the risk of any, hip, or vertebral fracture: A meta-analysis. Medicine. 2017;96(50):8458.
22. Feldtkeller E, Khan MA, van der Heijde D. et al. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol. Int. 2003;23(2):61-66.
